Evaluation of Belatacept as First-Line Immunosuppression

Project: Research project

Project Details

Description

Evaluation of Belatacept as First-Line Immunosuppression in DeNovo Liver Transplant Recipients: Long Term Extension (LTE)
StatusFinished
Effective start/end date8/10/0712/31/15

Funding

  • BRISTOL-MYERS SQUIBB COMPANY

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.